HC Wainwright Forecasts Edap Tms FY2029 Earnings

Edap Tms S.A. (NASDAQ:EDAP) – Research analysts at HC Wainwright issued their FY2029 EPS estimates for Edap Tms in a research note issued to investors on Friday, March 28th. HC Wainwright analyst S. Ramakanth anticipates that the medical equipment provider will post earnings of $0.40 per share for the year. HC Wainwright currently has a “Buy” rating and a $19.00 price target on the stock. The consensus estimate for Edap Tms’ current full-year earnings is ($0.60) per share.

Edap Tms (NASDAQ:EDAP) last released its quarterly earnings results on Thursday, March 27th. The medical equipment provider reported ($0.05) EPS for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.06. The company had revenue of $22.69 million for the quarter, compared to the consensus estimate of $20.83 million. Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%.

Other equities analysts have also recently issued reports about the company. Piper Sandler lowered their price target on Edap Tms from $5.00 to $4.50 and set an “overweight” rating on the stock in a research report on Friday. StockNews.com began coverage on Edap Tms in a research note on Friday. They set a “hold” rating for the company.

Edap Tms Price Performance

NASDAQ EDAP opened at $2.15 on Monday. The firm has a market capitalization of $79.77 million, a PE ratio of -3.31 and a beta of 0.37. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.18 and a quick ratio of 1.46. Edap Tms has a 12 month low of $1.96 and a 12 month high of $8.50. The company’s 50 day simple moving average is $2.42 and its 200 day simple moving average is $2.50.

Institutional Trading of Edap Tms

Large investors have recently added to or reduced their stakes in the business. Parkman Healthcare Partners LLC bought a new position in shares of Edap Tms in the third quarter valued at $395,000. Jane Street Group LLC grew its holdings in shares of Edap Tms by 174.7% in the 4th quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider’s stock worth $69,000 after acquiring an additional 73,361 shares during the last quarter. Schonfeld Strategic Advisors LLC raised its position in shares of Edap Tms by 48.5% during the fourth quarter. Schonfeld Strategic Advisors LLC now owns 160,800 shares of the medical equipment provider’s stock worth $355,000 after purchasing an additional 52,500 shares during the period. Millennium Management LLC raised its position in shares of Edap Tms by 218.5% during the fourth quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider’s stock worth $108,000 after purchasing an additional 33,558 shares during the period. Finally, BNP Paribas Financial Markets lifted its holdings in shares of Edap Tms by 111.5% during the fourth quarter. BNP Paribas Financial Markets now owns 48,650 shares of the medical equipment provider’s stock valued at $108,000 after purchasing an additional 25,650 shares during the last quarter. 62.74% of the stock is currently owned by institutional investors.

Edap Tms Company Profile

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.